Revance Therapeutic (RVNC) PT Lowered to $8 at Goldman Sachs
Goldman Sachs analyst Chris Shibutani ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)